Pulmatrix, Inc. — Director's Dealing 2018

Apr 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2018-04-03

Reporting Person: Iwicki Mark T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-03	Common Stock	P	307000	—	Acquired	307000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-03	Series A Warrant (right to buy)	$0.65	P	307000	Acquired	2018-10-03	Common Stock (307000)	Direct
2018-04-03	Series B Warrant (right to buy)	$0.75	P	307000	Acquired	2023-04-03	Common Stock (307000)	Direct

Footnotes

F1: The reported securities were included within 307,000 Units purchased by the reporting person for $0.65 per Unit. Each Unit consisted of one share of common stock, one Series A Warrant to purchase one share of common stock at an exercise price of $0.65 per share, and one Series B Warrant to purchase one share of common stock at an exercise price of $0.75 per share.